SAGENT PHARMACEUTICALS INC's ticker is SGNT and the CUSIP is 786692103. A total of 93 filers reported holding SAGENT PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $15,104,000 | -17.3% | 1,008,265 | -32.8% | 1.56% | +76.7% |
| Q1 2016 | $18,271,000 | +41.7% | 1,501,296 | +85.3% | 0.88% | +60.5% |
| Q4 2015 | $12,893,000 | +43.6% | 810,362 | +38.4% | 0.55% | +33.8% |
| Q3 2015 | $8,978,000 | -20.7% | 585,659 | +25.8% | 0.41% | -12.9% |
| Q2 2015 | $11,319,000 | -58.4% | 465,625 | -60.2% | 0.47% | -54.3% |
| Q1 2015 | $27,204,000 | +29.9% | 1,170,083 | +40.3% | 1.03% | +10.0% |
| Q4 2014 | $20,938,000 | -34.6% | 833,861 | -19.0% | 0.94% | -30.3% |
| Q3 2014 | $32,017,000 | +16.9% | 1,029,472 | -2.8% | 1.35% | +16.0% |
| Q2 2014 | $27,394,000 | +12.9% | 1,059,306 | +2.0% | 1.16% | +16.3% |
| Q1 2014 | $24,270,000 | +38.6% | 1,038,504 | +50.6% | 1.00% | +32.2% |
| Q4 2013 | $17,505,000 | +52.1% | 689,729 | +22.2% | 0.76% | +36.3% |
| Q3 2013 | $11,512,000 | -10.1% | 564,325 | -7.5% | 0.55% | +46.6% |
| Q2 2013 | $12,799,000 | – | 610,056 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Timpani Capital Management LLC | 110,215 | $2,248,000 | 1.32% |
| Healthcare Value Capital, LLC | 73,822 | $1,506,000 | 1.32% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,014,863 | $20,703,000 | 0.96% |
| Perimeter Capital Partners, LLC | 248,893 | $5,077,000 | 0.94% |
| Tekla Capital Management LLC | 270,031 | $5,509,000 | 0.61% |
| SECTORAL ASSET MANAGEMENT INC | 564,325 | $11,512,000 | 0.55% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 168,268 | $3,432,000 | 0.35% |
| MENTA CAPITAL LLC | 30,480 | $622,000 | 0.32% |
| KOPP INVESTMENT ADVISORS LLC | 39,934 | $815,000 | 0.30% |
| Broadfin Capital, LLC | 68,300 | $1,393,000 | 0.25% |